Omega-3 Fatty Acids and Glaucoma Risk

A retrospective cohort study published in Translational Vision Science & Technology suggests that
omega-3 fatty acid supplementation may significantly lower the risk of developing glaucoma in individuals with dry eye disease.

Researchers analyzed data from 14,168 adult patients across a multinational database between 2013 and 2023. They compared a group prescribed omega-3 supplements against a matched control group over a five-year follow-up period.

Key Findings

Compared to the control group, patients who received omega-3 supplements experienced substantially lower risks across multiple conditions:

  • Total Glaucoma: Risk reduced by 52% (HR: 0.48)

  • Primary Open-Angle Glaucoma (POAG): Risk reduced by 55% (HR: 0.45)

  • Normal-Tension Glaucoma (NTG): Risk reduced by 59% (HR: 0.41)

  • Ocular Hypertension: Risk reduced by 43% (HR: 0.57)

  • Primary Angle-Closure Glaucoma (PACG): Risk reduced by 55% (HR: 0.45)

  • First-Line Glaucoma Medication Use: Risk reduced by 35% (HR: 0.65)


Biological Mechanisms & Next Steps

The protective benefits remained consistent across various demographics, including women, individuals aged 60 or older, and Caucasian populations. Researchers highlight that omega-3s potentially decrease risk by:

  • Lowering intraocular pressure (IOP)

  • Enhancing blood flow to the eyes

  • Providing neuroprotection to retinal ganglion cells

  • Mitigating inflammation and oxidative stress

Note: While these findings indicate that omega-3 intake could complement current preventative strategies, the authors emphasize that randomized controlled trials are still necessary to confirm direct causality and establish optimal dosages.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

Keratoconus and Inflammatory Skin Conditions

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH